Simultaneous Resection of Primary Colorectal Cancer and Synchronous Liver Metastases: Contemporary Practice, Evidence and Knowledge Gaps

Dyre Kleive, Eline Aas, Jon-Helge Angelsen, Erling A Bringeland, Arild Nesbakken, Linn S Nymo, Johannes K Schultz, Kjetil Søreide, Sheraz Yaqub, Dyre Kleive, Eline Aas, Jon-Helge Angelsen, Erling A Bringeland, Arild Nesbakken, Linn S Nymo, Johannes K Schultz, Kjetil Søreide, Sheraz Yaqub

Abstract

The timing of surgical resection of synchronous liver metastases from colorectal cancer has been debated for decades. Several strategies have been proposed, but high-level evidence remains scarce. Simultaneous resection of the primary tumour and liver metastases has been described in numerous retrospective audits and meta-analyses. The potential benefits of simultaneous resections are the eradication of the tumour burden in one procedure, overall shorter procedure time, reduced hospital stay with the likely benefits on quality of life and an expected reduction in the use of health care services compared to staged procedures. However, concerns about accumulating complications and oncological outcomes remain and the optimal selection criteria for whom simultaneous resections are beneficial remains undetermined. Based on the current level of evidence, simultaneous resection should be restricted to patients with a limited liver tumour burden. More high-level evidence studies are needed to evaluate the quality of life, complication burden, oncological outcomes, as well as overall health care implications for simultaneous resections.

Keywords: Colorectal cancer; Colorectal resection; Liver resection; Simultaneous resection; Surgical oncology; Surgical outcomes; Synchronous liver metastasis.

References

    1. Jones TJ, Murphy AE, Tameron A, Hussain LR, Grannan K, Guend H, et al. Trends and outcomes of synchronous resection of colorectal metastasis in the modern era-analysis of targeted hepatic NSQIP database. J Surg Res. 2019;238:35–40. doi: 10.1016/j.jss.2019.01.021.
    1. Snyder RA, Hao S, Irish W, Zervos EE, Tuttle-Newhall JE, Parikh AA. Thirty-day morbidity after simultaneous resection of colorectal cancer and colorectal liver metastasis: american college of surgeons NSQIP analysis. J Am Coll Surg. 2020;230(4):617–27.e9. doi: 10.1016/j.jamcollsurg.2019.12.018.
    1. Kelly ME, Spolverato G, Lê GN, Mavros MN, Doyle F, Pawlik TM, et al. Synchronous colorectal liver metastasis: a network meta-analysis review comparing classical, combined, and liver-first surgical strategies. J Surg Oncol. 2015;111(3):341–351. doi: 10.1002/jso.23819.
    1. Vallance AE, van der Meulen J, Kuryba A, Charman SC, Botterill ID, Prasad KR, et al. The timing of liver resection in patients with colorectal cancer and synchronous liver metastases: a population-based study of current practice and survival. Colorectal Dis. 2018;20(6):486–495. doi: 10.1111/codi.14019.
    1. Baltatzis M, Chan AK, Jegatheeswaran S, Mason JM, Siriwardena AK. Colorectal cancer with synchronous hepatic metastases: systematic review of reports comparing synchronous surgery with sequential bowel-first or liver-first approaches. Euro J Surg Oncol. 2016;42(2):159–165. doi: 10.1016/j.ejso.2015.11.002.
    1. Feng Q, Wei Y, Zhu D, Ye L, Lin Q, Li W, et al. Timing of hepatectomy for resectable synchronous colorectal liver metastases: for whom simultaneous resection is more suitable–a meta-analysis. PLoS ONE. 2014;9(8):e104348. doi: 10.1371/journal.pone.0104348.
    1. Gavriilidis P, Sutcliffe RP, Hodson J, Marudanayagam R, Isaac J, Azoulay D, et al. Simultaneous versus delayed hepatectomy for synchronous colorectal liver metastases: a systematic review and meta-analysis. HPB. 2018;20(1):11–19. doi: 10.1016/j.hpb.2017.08.008.
    1. Hillingsø JG, Wille-Jørgensen P. Staged or simultaneous resection of synchronous liver metastases from colorectal cancer–a systematic review. Colorectal Dis. 2009;11(1):3–10. doi: 10.1111/j.1463-1318.2008.01625.x.
    1. Slesser AA, Simillis C, Goldin R, Brown G, Mudan S, Tekkis PP. A meta-analysis comparing simultaneous versus delayed resections in patients with synchronous colorectal liver metastases. Surg Oncol. 2013;22(1):36–47.
    1. Yin Z, Liu C, Chen Y, Bai Y, Shang C, Yin R, et al. Timing of hepatectomy in resectable synchronous colorectal liver metastases (SCRLM): simultaneous or delayed? Hepatology (Baltimore, MD) 2013;57(6):2346–2357. doi: 10.1002/hep.26283.
    1. De Raffele E, Mirarchi M, Cuicchi D, Lecce F, Casadei R, Ricci C, et al. Simultaneous colorectal and parenchymal-sparing liver resection for advanced colorectal carcinoma with synchronous liver metastases: between conventional and mini-invasive approaches. World J Gastroenterol. 2020;26(42):6529–6555. doi: 10.3748/wjg.v26.i42.6529.
    1. Brouquet A, Mortenson MM, Vauthey JN, Rodriguez-Bigas MA, Overman MJ, Chang GJ, et al. Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy? J Am Coll Surg. 2010;210(6):934–941. doi: 10.1016/j.jamcollsurg.2010.02.039.
    1. Sturesson C, Valdimarsson VT, Blomstrand E, Eriksson S, Nilsson JH, Syk I, et al. Liver-first strategy for synchronous colorectal liver metastases—an intention-to-treat analysis. HPB. 2017;19(1):52–58. doi: 10.1016/j.hpb.2016.10.005.
    1. Welsh FK, Chandrakumaran K, John TG, Cresswell AB, Rees M. Propensity score-matched outcomes analysis of the liver-first approach for synchronous colorectal liver metastases. Br J Surg. 2016;103(5):600–606. doi: 10.1002/bjs.10099.
    1. Boudjema K, Locher C, Sabbagh C, Ortega-Deballon P, Heyd B, Bachellier P, et al. Simultaneous versus delayed resection for initially resectable synchronous colorectal cancer liver metastases: a prospective, open-label, randomized. Controlled Trial Ann Surg. 2021;273(1):49–56.
    1. Huiskens J, Bolhuis K, Engelbrecht MR, De Jong KP, Kazemier G, Liem MS, et al. Outcomes of resectability assessment of the Dutch colorectal cancer group liver metastases expert panel. J Am Coll Surg. 2019;229(6):523–32.e2. doi: 10.1016/j.jamcollsurg.2019.08.1445.
    1. Sandström P, Røsok BI, Sparrelid E, Larsen PN, Larsson AL, Lindell G, et al. ALPPS improves resectability compared with conventional two-stage hepatectomy in patients with advanced colorectal liver metastasis: results from a Scandinavian multicenter randomized controlled trial (LIGRO Trial) Ann Surg. 2018;267(5):833–840. doi: 10.1097/SLA.0000000000002511.
    1. Dorcaratto D, Mazzinari G, Fernandez M, Muñoz E, Garcés-Albir M, Ortega J, et al. Impact of postoperative complications on survival and recurrence after resection of colorectal liver metastases: systematic review and meta-analysis. Ann Surg. 2019;270(6):1018–1027. doi: 10.1097/SLA.0000000000003254.
    1. Driedger MR, Yamashita TS, Starlinger P, Mathis KL, Smoot RL, Cleary SP, et al. Synchronous resection of colorectal cancer primary and liver metastases: an outcomes analysis. HPB. 2021.
    1. Spampinato MG, Mandalá L, Quarta G, Del Medico P, Baldazzi G. One-stage, totally laparoscopic major hepatectomy and colectomy for colorectal neoplasm with synchronous liver metastasis: safety, feasibility and short-term outcome. Surgery. 2013;153(6):861–865. doi: 10.1016/j.surg.2012.06.007.
    1. Adam R, de Gramont A, Figueras J, Kokudo N, Kunstlinger F, Loyer E, et al. Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus. Cancer Treat Rev. 2015;41(9):729–741. doi: 10.1016/j.ctrv.2015.06.006.
    1. Shubert CR, Habermann EB, Bergquist JR, Thiels CA, Thomsen KM, Kremers WK, et al. A NSQIP review of major morbidity and mortality of synchronous liver resection for colorectal metastasis stratified by extent of liver resection and type of colorectal resection. J Gastrointestinal Surg. 2015;19(11):1982–1994. doi: 10.1007/s11605-015-2895-z.
    1. Griffiths C, Bogach J, Simunovic M, Parpia S, Ruo L, Hallet J, et al. Simultaneous resection of colorectal cancer with synchronous liver metastases; a practice survey. HPB. 2020;22(5):728–734. doi: 10.1016/j.hpb.2019.09.012.
    1. Boeckx N, Koukakis R, Op de Beeck K, Rolfo C, Van Camp G, Siena S, et al. Primary tumor sidedness has an impact on prognosis and treatment outcome in metastatic colorectal cancer: results from two randomized first-line panitumumab studies. Ann Oncol. 2017;28(8):1862–8.
    1. Brudvik KW, Jones RP, Giuliante F, Shindoh J, Passot G, Chung MH, et al. RAS mutation clinical risk score to predict survival after resection of colorectal liver metastases. Ann Surg. 2019;269(1):120–126. doi: 10.1097/SLA.0000000000002319.
    1. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230(3):309–18; discussion 18–21.
    1. Ooki A, Akagi K, Yatsuoka T, Asayama M, Hara H, Nishimura Y, et al. Lymph node ratio as a risk factor for recurrence after adjuvant chemotherapy in stage III colorectal cancer. J Gastrointestinal Surg. 2017;21(5):867–878. doi: 10.1007/s11605-017-3382-5.
    1. Ahmad A, Reha J, Saied A, Espat NJ, Somasundar P, Katz SC. Association of primary tumor lymph node ratio with burden of liver metastases and survival in stage IV colorectal cancer. Hepatobiliary Surg Nutr. 2017;6(3):154–161. doi: 10.21037/hbsn.2016.08.08.
    1. van Amerongen MJ, van der Stok EP, Fütterer JJ, Jenniskens SF, Moelker A, Grünhagen DJ, et al. Short term and long term results of patients with colorectal liver metastases undergoing surgery with or without radiofrequency ablation. Euro J Surg Oncol. 2016;42(4):523–530. doi: 10.1016/j.ejso.2016.01.013.
    1. . Accessed 21.02.21
    1. Bosker RJI, Van't Riet E, de Noo M, Vermaas M, Karsten TM, Pierie JP. Minimally invasive versus open approach for right-sided colectomy: a study in 12,006 patients from the Dutch surgical colorectal audit. Dig Surg. 2019;36(1):27–32. doi: 10.1159/000486400.
    1. Fretland ÅA, Dagenborg VJ, Bjørnelv GMW, Kazaryan AM, Kristiansen R, Fagerland MW, et al. Laparoscopic versus open resection for colorectal liver metastases: the OSLO-COMET randomized controlled trial. Ann Surg. 2018;267(2):199–207. doi: 10.1097/SLA.0000000000002353.
    1. Aghayan DL, Kazaryan AM, Dagenborg VJ, Røsok BI, Fagerland MW, Bjørnelv GMW, et al. Long-term oncologic outcomes after laparoscopic versus open resection for colorectal liver metastases : a randomized trial. Ann Int Med. 2020.
    1. Feinberg AE, Chesney TR, Acuna SA, Sammour T, Quereshy FA. Oncologic outcomes following laparoscopic versus open resection of pT4 colon cancer: a systematic review and meta-analysis. Dis Colon Rectum. 2017;60(1):116–125. doi: 10.1097/DCR.0000000000000641.
    1. Olthof PB, Elfrink AKE, Marra E, Belt EJT, van den Boezem PB, Bosscha K, et al. Volume-outcome relationship of liver surgery: a nationwide analysis. Br J Surg. 2020;107(7):917–926. doi: 10.1002/bjs.11586.
    1. Huo YR, Phan K, Morris DL, Liauw W. Systematic review and a meta-analysis of hospital and surgeon volume/outcome relationships in colorectal cancer surgery. J Gastrointestinal Oncol. 2017;8(3):534–546. doi: 10.21037/jgo.2017.01.25.
    1. Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet (London, England). 2008;371(9617):1007–1016. doi: 10.1016/S0140-6736(08)60455-9.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe